Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

BlueCrest’ systematic trend following hedge fund loses almost 17% in six weeks - Reuters

Friday, July 05, 2013

Benedicte Gravrand, Opalesque Geneva:

The BlueTrend fund, one of BlueCrest Capital Management’s systematic trend-following hedge funds, has recently had one of its worst ever peak-to-trough losses, writes Laurence Fletcher of Reuters. He adds that a listed feeder fund that channels capital into the $16 billion BlueTrend fund has indeed lost 16.9% between May 17 and June 28. The Feeder replicates the performance of the flagship fund. This equates to a loss of around $2.7bn in the main fund, which has never had a losing calendar year since its 2004 launch.

According to Trustnet.com, BlueCrest’s BlueTrend fund (USD class)’s estimated NAV of the fund’s ordinary share was $0.89 as of 28th June.

Bloomberg reported last week that the $14 billion hedge fund BlueTrend had lost 8.3% in June (and -9.2% in 2013). The fund produced an average annual return of 12.9% since its inception in 2004.

Systematic funds did not fare well in May either. The Barclay CTA Index went down 1.31% in May (+0.61% YTD). "May’s tren......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner